• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enfusion Inc Cl A (NY: ENFN )

    9.790 -0.090 (-0.91%)
    Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Enfusion Inc Cl A

    < Previous 1 2 3 4 Next >
    Enfusion Announces Third Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
    From Enfusion, Inc.
    Via Business Wire
    Enfusion Announces Date of Third Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
    Via Benzinga
    Earnings Outlook For Enfusion
    Via Benzinga
    JP Morgan Downgrades Enfusion: Here's What You Need To Know
    Via Benzinga
    ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
    ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Enfusion Announces Second Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
    From Enfusion, Inc.
    Via Business Wire
    Enfusion Announces Date of Second Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    Enfusion To Present at Upcoming Investor Events
    From Enfusion, Inc.
    Via Business Wire
    ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024
    ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Enfusion Announces First Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    Enfusion Announces Date of First Quarter 2024 Results
    From Enfusion, Inc.
    Via Business Wire
    The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
    Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April. 
    Via InvestorPlace
    Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
    From Enfusion
    Via Business Wire
    Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
    U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10. 
    Via InvestorPlace
    12 Information Technology Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
    From Enfusion, Inc.
    Via Business Wire
    Wall Street's Top 10 Stock Calls This Week - Saturday, March 2
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1. 
    Via Talk Markets
    Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
    Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific... 
    Via Benzinga
    Earnings Scheduled For March 12, 2024
    Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
    Via Benzinga
    Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
    From Enfusion, Inc.
    Via Business Wire
    Enfusion to Host Investor Day on March 19, 2024
    From Enfusion, Inc.
    Via Business Wire
    This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
    U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential
    These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.